K072264 is an FDA 510(k) clearance for the FASTPACK HCG IMMUNOASSAY. Classified as Visual, Pregnancy Hcg, Prescription Use (product code JHI), Class II - Special Controls.
Submitted by Qualigen, Inc. (Carlsbad, US). The FDA issued a Cleared decision on December 6, 2007 after a review of 113 days - within the typical 510(k) review window.
This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1155 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.